Literature DB >> 29122833

Advanced therapies push regulatory boundaries: Novel therapeutic approaches require more regulatory flexibility and transparency.

Philip Hunter1.   

Abstract

Mesh：

Year:  2017        PMID： 29122833      PMCID： PMC5709725          DOI： 10.15252/embr.201745345

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  5 in total

1.  Stem cells: taking a stand against pseudoscience.

Authors:  Elena Cattaneo; Gilberto Corbellini
Journal:  Nature       Date:  2014-06-19       Impact factor: 49.962

Review 2.  Recombinant viral vaccines for cancer.

Authors:  Ryan Cawood; Thomas Hills; Suet Ling Wong; Aliaa A Alamoudi; Storm Beadle; Kerry D Fisher; Leonard W Seymour
Journal:  Trends Mol Med       Date:  2012-08-21       Impact factor: 11.951

3.  Compassionate use of experimental therapies: who should decide?

Authors:  Patricia J Zettler
Journal:  EMBO Mol Med       Date:  2015-10       Impact factor: 12.137

Review 4.  The Current Use of Stem Cells in Bladder Tissue Regeneration and Bioengineering.

Authors:  Yvonne Y Chan; Samantha K Sandlin; Eric A Kurzrock; Stephanie L Osborn
Journal:  Biomedicines       Date:  2017-01-06

Review 5.  Safety of Cultivated Limbal Epithelial Stem Cell Transplantation for Human Corneal Regeneration.

Authors:  J Behaegel; S Ní Dhubhghaill; C Koppen; N Zakaria
Journal:  Stem Cells Int       Date:  2017-03-30       Impact factor: 5.443
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.